ASLAN Pharmaceuticals Limited logo
ASLAN Pharmaceuticals Limited ASLN

Annual report 2020
added 08-19-2023

report update icon

ASLAN Pharmaceuticals Limited Interest Expense 2011-2026 | ASLN

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.
Includes:
  • Interest on bank loans
  • Interest on corporate bonds
  • Interest on leases
  • Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense ASLAN Pharmaceuticals Limited

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
443 K 431 K 436 K 441 K 417 K 418 K - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
443 K 417 K 431 K

Interest Expense of other stocks in the Biotechnology industry

Issuer Interest Expense Price % 24h Market Cap Country
FSD Pharma FSD Pharma
HUGE
9.34 K - 5743.5 % $ 69.7 M canadaCanada
MorphoSys AG MorphoSys AG
MOR
4.66 M - 2.43 % $ 254 M germanyGermany
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
262 K - 1.35 % $ 17.8 M chinaChina
AgeX Therapeutics AgeX Therapeutics
AGE
51 K - -10.17 % $ 12.2 K usaUSA
I-Mab I-Mab
IMAB
722 K - - $ 866 M chinaChina
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
16.4 M - - $ 2.18 B usaUSA
Genfit SA Genfit SA
GNFT
4.68 M - 2.54 % $ 160 B franceFrance
BioNTech SE BioNTech SE
BNTX
14.2 M $ 89.59 - $ 21.7 B germanyGermany
Compugen Ltd. Compugen Ltd.
CGEN
281 K $ 2.22 - $ 207 M israelIsrael
Coherus BioSciences Coherus BioSciences
CHRS
9 M $ 1.58 - $ 185 M usaUSA
Athira Pharma Athira Pharma
ATHA
1.24 M - - $ 269 M usaUSA
Galera Therapeutics Galera Therapeutics
GRTX
11.4 M - -32.59 % $ 7.61 M usaUSA
Berkeley Lights Berkeley Lights
BLI
910 K - -7.31 % $ 87 M usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
927 K $ 29.93 - $ 1.99 B usaUSA
IMV IMV
IMV
2.34 K - - $ 13.1 M canadaCanada
Akero Therapeutics Akero Therapeutics
AKRO
4.67 M - - $ 3.67 B usaUSA
Akouos Akouos
AKUS
-1.72 M - 0.23 % $ 488 M usaUSA
Enlivex Therapeutics Ltd. Enlivex Therapeutics Ltd.
ENLV
1.93 M $ 0.79 - $ 36.1 M israelIsrael
Esperion Therapeutics Esperion Therapeutics
ESPR
3.49 M $ 3.13 - $ 651 M usaUSA
Eton Pharmaceuticals Eton Pharmaceuticals
ETON
1.06 M $ 28.9 - $ 778 M usaUSA
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
354 K - -4.36 % $ 27 M usaUSA
Freeline Therapeutics Holdings plc Freeline Therapeutics Holdings plc
FRLN
2.15 M - - $ 384 M britainBritain
Forte Biosciences Forte Biosciences
FBRX
-396 K $ 16.69 - $ 216 M usaUSA
Gracell Biotechnologies Gracell Biotechnologies
GRCL
6.74 M - - $ 3.37 B chinaChina
Advaxis Advaxis
ADXS
28 K - -9.65 % $ 45.9 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
29.5 M - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
2.67 M - - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
-5.79 M - 1.93 % $ 17.4 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
561 K $ 3.16 - $ 5.2 M israelIsrael
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
86.6 M $ 56.95 - $ 5.12 B schweizSchweiz
Aptinyx Aptinyx
APTX
737 K - -39.0 % $ 4.57 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
3.69 M - -0.23 % $ 916 M usaUSA
Galectin Therapeutics Galectin Therapeutics
GALT
2.79 M $ 2.38 - $ 152 M usaUSA